 |
市场调查报告书
商品编码
1402597
多克隆抗体市场：按类型、来源、应用、最终用户、地区Polyclonal Antibody Market, By Type, By Source, By Application, By End User,, By Region |
||||||
价格
简介目录
全球多株抗体市场规模预计将从 2023 年的 10.969 亿美元增至 2030 年的 16.387 亿美元，预测期内复合年增长率为 5.9%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023年市场规模 | 10.969 亿美元 |
| 过去的资料 | 2018-2021 | 预测期 | 2023-2030 |
| 预测期复合年增长率 | 5.90% | 2030年市场规模预测 | 16.387 亿美元 |
图 1. 2023 年按地区分類的多克隆抗体全球市场占有率(%)
多克隆抗体是非特异性结合抗原上多个抗原决定位点的免疫球蛋白。它通常是透过将抗原註射到动物体内并收集含有免疫球蛋白的血清来产生的。各种慢性病和感染疾病患者病率上升、製药和生物技术领域研发投资增加以及多克隆抗体越来越多地用于研究应用等因素预计将推动该市场的成长。然而，严格的产品核可监管指南可能会在一定程度上阻碍市场成长。多克隆抗体是一种源自多个 B 细胞免疫反应的异质抗体，每个 B 细胞辨识同一抗原上的不同表位。多克隆抗体由代表对抗原的先天免疫反应的抗体混合物组成。多克隆抗体用于一般研究目的。
市场动态：
由于慢性病和感染疾病病率上升以及各种研究应用的采用不断增加等各种驱动因素，预计全球多克隆抗体市场在预测期内将稳步增长。此外，诊断技术的持续技术创新以及向多克隆抗体的快速转变（作为单株抗体的更便宜替代品）预计也将刺激需求。然而，与多克隆抗体精製和异质性相关的高成本以及严格的监管核准给市场带来了重大挑战。同时，先进精製技术、标记製程和重组抗体製造的发展将在预测期内创造成长机会。
本研究的主要特点
- 本报告对全球多克隆抗体市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
- 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
- 该报告根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球多克隆抗体市场的主要企业。
- 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
- 全球多克隆抗体市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 透过用于分析全球多克隆抗体市场的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 增加产品发布
- 主要市场参与者之间的合作伙伴关係
- 抑制因素
- 生产多株抗体的成本较高
- 严格规定
- 市场机会
- 扩大多克隆抗体在诊断上的应用
- 采用重组多株抗体
- 影响分析
- 监管指引
- 产品发表会
- 主要进展
- PEST分析
- 波特的分析
- 监管场景
- 併购
- 製造商收益
- 按国家/地区分類的医疗保健支出
第四章全球多株抗体市场-COVID-19的影响分析
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球多株抗体市场，依类型，2018-2030
- 一抗
- 二抗
第六章 全球多株抗体市场（依来源），2018-2030 年
- 兔子
- 山羊
- 羊
- 其他（大鼠等）
第七章 全球多株抗体市场（依应用），2018-2030
- 学术研究
- 诊断
- 其他的
第 8 章 全球多株抗体市场，依最终使用者划分，2018-2030 年
- 学术研究所
- 製药和生物技术公司
- 其他（诊断中心等）
第9章2018-2030年全球多株抗体市场（按地区）
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- GCC
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第10章竞争形势
- Thermo Fisher Scientific Inc.
- Santa Cruz Biotechnology, Inc.
- GenScript
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- BioLegend, Inc.
- GeneTex
- ROCKLAND IMMUNOCHEMICALS, INC.
- Abcam plc.
- Creative Diagnostics
- Crown Bioscience
- Takara Bio Inc.
- Geno Technology Inc.
- IGY Immune Technologies and Life Sciences Inc.
- EpigenTek Group Inc.
- Takeda Pharmaceutical Company Limited
- SAB Biotherapeutics
第11章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI4347
The global polyclonal antibody market size is expected to reach US$ 1,638.7 Mn by 2030, from US$ 1,096.9 Mn in 2023, exhibiting compound annual growth rate (CAGR) of 5.9% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 1,096.9 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 5.90% | 2030 Value Projection: | US$ 1,638.7 Mn |
Figure 1. Global Polyclonal Antibody Market Share (%), By Region, 2023
Polyclonal antibodies are immunoglobulin that bind nonspecifically to multiple epitopes of an antigen. They are commonly produced by injecting the antigen into an animal and harvesting the resulting serum containing the immunoglobulin. Factors such as the rising prevalence of various chronic and infectious diseases, increasing research and development investments in the pharmaceutical and biotechnology sectors, and the growing adoption of polyclonal antibodies for research applications are expected to drive the growth of this market. However, stringent regulatory guidelines for product approval may impede market growth to some extent. Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Polyclonal antibodies are used in general research applications
Market Dynamics:
The global polyclonal antibody market is projected to grow at a steady pace during the forecast period owing to various driving factors such as rising prevalence of chronic and infectious diseases, and growing adoption in various research applications. Furthermore, ongoing innovations in diagnostic technology and a rapid shift towards polyclonal antibodies as an inexpensive alternative to monoclonal antibodies are expected to boost demand. However, the high costs associated with the purification and heterogeneity of polyclonal antibodies along with stringent regulatory approvals, pose major challenges to the market. On the other hand, development of advanced purification techniques, labeling processes, and recombinant antibody production creates growth opportunities during the forecast period
Key features of the study:
- This report provides an in-depth analysis of the global polyclonal antibody market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global polyclonal antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Santa Cruz Biotechnology, Inc., GenScript, Merck KGaA, Bio-Rad Laboratories, Inc., BioLegend, Inc., GeneTex, ROCKLAND IMMUNOCHEMICALS, INC., Abcam plc., Creative Diagnostics, Crown Bioscience, Takara Bio Inc., Geno Technology Inc., IGY Immune Technologies and Life Sciences Inc., EpigenTek Group Inc., Takeda Pharmaceutical Company Limited and SAB Biotherapeutics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global polyclonal antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing global polyclonal antibody market
Detailed Segmentation:
- Global Polyclonal Antibody Market, Type:
- Primary Antibody
- Secondary Antibody
- Global Polyclonal Antibody Market, Source:
- Rabbits
- Goats
- Sheep
- Others
- Global Polyclonal Antibody Market, By Application:
- Academic Research
- Diagnostics
- Others
- Global Polyclonal Antibody Market, By End User:
- Academic & Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
- Global Polyclonal Antibody Market , By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Thermo Fisher Scientific Inc.
- Santa Cruz Biotechnology, Inc.
- GenScript
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- BioLegend, Inc.
- GeneTex
- ROCKLAND IMMUNOCHEMICALS, INC.
- Abcam plc.
- Creative Diagnostics
- Crown Bioscience
- Takara Bio Inc.
- Geno Technology Inc.
- IGY Immune Technologies and Life Sciences Inc.
- EpigenTek Group Inc.
- Takeda Pharmaceutical Company Limited
- SAB Biotherapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Source
- Market Snapshot, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trend Analysis
- Market Dynamics
- Drivers
- Increasing product launch
- Partnerships among key market players
- Restraints
- The high costs associated with polyclonal antibody production
- Stringent regulations
- Market Opportunities
- Growing applications of polyclonal antibodies in diagnostics
- Adoption of recombinant polyclonal antibodies
- Impact Analysis
- Regulatory Guidelines
- Product launches
- Key Development
- PEST Analysis
- PORTER's Analysis
- Regulatory Scenario
- Mergers and Acquisitions
- Manufacturer Revenue
- Healthcare Spending by Country
4. Global Polyclonal Antibody Market - COVID-19 Impact Analysis
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Polyclonal Antibody Market, By Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Primary Antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Secondary Antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Global Polyclonal Antibody Market, By Source, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Rabbits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Goats
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Sheep
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Others (Rats, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
7. Global Polyclonal Antibody Market, By Application, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Academic Research
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Global Polyclonal Antibody Market, By End User, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Pharmaceutical and Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Others (Diagnostic Centers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
9. Global Polyclonal Antibody Market , By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country, 2019-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2018- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018- 2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Santa Cruz Biotechnology, Inc.
- GenScript
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- BioLegend, Inc.
- GeneTex
- ROCKLAND IMMUNOCHEMICALS, INC.
- Abcam plc.
- Creative Diagnostics
- Crown Bioscience
- Takara Bio Inc.
- Geno Technology Inc.
- IGY Immune Technologies and Life Sciences Inc.
- EpigenTek Group Inc.
- Takeda Pharmaceutical Company Limited
- SAB Biotherapeutics
11. Section
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
研究抗体市场：按适应症、按操作、按产品、按来源、按技术、按类型、按最终用户 - 2024-2030 年，全球预测
抗体发现市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按抗体类型、性质、服务、最终用户和地理位置
全球抗体药物复合体市场：2024年至2029年预测
抗体生产市场：按产品类型、製程和最终用户划分 - 2024-2030 年全球预测
抗体药物复合体契约製造市场：按连结器、条件和最终用途划分 - 2024-2030 年全球预测
研究抗体的全球市场![抗体治疗市场- 按类型[单株抗体(mAb) {肿瘤、自体免疫疾病、传染病}、抗体药物偶联物(ADC)]、按最终用途（医院、专科中心）划分- 全球预测，2023年- 2032 年](/sample/img/cover/42/1416204.png)
抗体治疗市场- 按类型[单株抗体(mAb) {肿瘤、自体免疫疾病、传染病}、抗体药物偶联物(ADC)]、按最终用途（医院、专科中心）划分- 全球预测，2023年- 2032 年
全球抗体生产市场规模、份额、成长分析（按产品类型、按流程划分）- 产业预测，2023-2030 年
抗体药物偶联物市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测
多株抗体抗体市场规模 - 按产品（一抗、二抗）、应用、给药途径（IV、SC）、来源（兔、山羊、小鼠、人类）、最终用户、全球预测（2023-2032）
▼